Quest Diagnostics Inc vs Peloton Interactive Inc — how do they compare? Quest Diagnostics Inc trades at $205.45 (market cap $22.80B), while Peloton Interactive Inc trades at $6.18 (market cap $2.67B). The key difference: Quest Diagnostics Inc is far larger — about 8.5× Peloton Interactive Inc's market cap, and Quest Diagnostics Inc pays a 1.67% dividend while Peloton Interactive Inc pays none. Which is the better fit depends on your goals.
| DGX | PTON | |
|---|---|---|
Market Cap | $22.80B | $2.67B |
Sector | Health | Consumer Cyclical |
52-Week High | $216.02 | $9.00 |
52-Week Low | $166.42 | $3.71 |
Enterprise Value | $28.82B | $3.27B |
Dividend Yield | 1.67% | — |
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $207.35, showing minimal daily movement with a slight decline of 0.04%. The stock maintains a bullish technical stance with recent earnings beats and analyst consensus pointing to upside potential. Recent developments include New York State approval for Haystack MRD testing and strong momentum across diagnostic channels. Revenue growth accelerated to $11.04 billion in 2025 with consistent profitability margins around 9%.
DGX presents a balanced investment case with 38% analyst buy ratings and a $227.75 price target suggesting 10% upside. The company demonstrates steady revenue growth and operational efficiency, though elevated debt levels and policy risks require monitoring. Second quarter earnings on July 23, 2026, will be crucial for validating current momentum and growth trajectory.
Peloton (PTON) trades at $6.08, up 3.75% on the day, as technical indicators show a bullish trend with neutral oscillators. The company has achieved a significant turnaround in cash flow, with operating cash flow positive at $333 million in 2025, and is projected to return to net profitability in 2026. However, revenue continues to decline, and the stock carries a high P/E ratio of 101.25, reflecting investor optimism about future earnings despite current challenges. Recent news highlights inclusion in the S&P SmallCap 600 index and leadership changes.
The outlook for PTON hinges on sustaining profitability and reversing revenue declines. Opportunities include strong free cash flow generation and cost-cutting success, but risks involve persistent revenue shrinkage, high debt levels, and intense competition. Analyst consensus is cautiously optimistic with a $7.50 price target, suggesting potential upside if execution improves.
Trailing returns across standard periods
Latest headlines on both assets
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →